162 related articles for article (PubMed ID: 35138442)
1. Prevalence and clinical predictors of inappropriate direct oral anticoagulant dosage in octagenarians with atrial fibrillation.
Carbone A; Santelli F; Bottino R; Attena E; Mazzone C; Parisi V; D'Andrea A; Golino P; Nigro G; Russo V
Eur J Clin Pharmacol; 2022 May; 78(5):879-886. PubMed ID: 35138442
[TBL] [Abstract][Full Text] [Related]
2. Clinical profile of direct oral anticoagulants versus vitamin K anticoagulants in octogenarians with atrial fibrillation: a multicentre propensity score matched real-world cohort study.
Russo V; Attena E; Di Maio M; Mazzone C; Carbone A; Parisi V; Rago A; D'Onofrio A; Golino P; Nigro G
J Thromb Thrombolysis; 2020 Jan; 49(1):42-53. PubMed ID: 31385163
[TBL] [Abstract][Full Text] [Related]
3. The Comparison of Inappropriate-Low-Doses Use among 4 Direct Oral Anticoagulants in Patients with Atrial Fibrillation: From the Database of a Single-Center Registry.
Sato T; Aizawa Y; Fuse K; Fujita S; Ikeda Y; Kitazawa H; Takahashi M; Okabe M
J Stroke Cerebrovasc Dis; 2018 Nov; 27(11):3280-3288. PubMed ID: 30121155
[TBL] [Abstract][Full Text] [Related]
4. Clinical impact of oral anticoagulation among octogenarians with atrial fibrillation and anaemia.
Carbone A; Bottino R; Attena E; Parisi V; Conte M; D'Andrea A; Imbalzano E; Golino P; Russo V
J Thromb Thrombolysis; 2023 Feb; 55(2):222-227. PubMed ID: 36472719
[TBL] [Abstract][Full Text] [Related]
5. Appropriateness of direct oral anticoagulant prescribing in older subjects with atrial fibrillation discharged from acute medical wards.
De Vincentis A; Soraci L; Arena E; Sciacqua A; Armentaro G; Aucella F; Corsonello A; Aucella F; Antonelli Incalzi R
Br J Clin Pharmacol; 2024 May; 90(5):1231-1239. PubMed ID: 38321367
[TBL] [Abstract][Full Text] [Related]
6. Oral Anticoagulation for Atrial Fibrillation in Octogenarians Across the Renal Function Spectrum.
Carbone A; Bottino R; Attena E; Parisi V; Conte M; D'Andrea A; Imbalzano E; Alfredo C; Russo V
Cardiovasc Drugs Ther; 2023 Dec; ():. PubMed ID: 38108919
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of Direct Oral Anticoagulants in Patients With Atrial Fibrillation and Extreme Obesity.
Russo V; Cattaneo D; Giannetti L; Bottino R; Laezza N; Atripaldi U; Clementi E
Clin Ther; 2021 Sep; 43(9):e255-e263. PubMed ID: 34366151
[TBL] [Abstract][Full Text] [Related]
8. Clinical Benefit of Direct Oral Anticoagulants Versus Vitamin K Antagonists in Patients with Atrial Fibrillation and Bioprosthetic Heart Valves.
Russo V; Carbone A; Attena E; Rago A; Mazzone C; Proietti R; Parisi V; Scotti A; Nigro G; Golino P; D'Onofrio A
Clin Ther; 2019 Dec; 41(12):2549-2557. PubMed ID: 31735436
[TBL] [Abstract][Full Text] [Related]
9. Prescription Patterns and Outcomes of Patients With Atrial Fibrillation Treated With Direct Oral Anticoagulants and Warfarin: A Real-World Analysis.
Kattoor AJ; Pothineni NV; Goel A; Syed M; Syed S; Paydak H; Mehta JL
J Cardiovasc Pharmacol Ther; 2019 Sep; 24(5):428-434. PubMed ID: 31035795
[TBL] [Abstract][Full Text] [Related]
10. Rates of Potentially Inappropriate Dosing of Direct-Acting Oral Anticoagulants and Associations With Geriatric Conditions Among Older Patients With Atrial Fibrillation: The SAGE-AF Study.
Sanghai S; Wong C; Wang Z; Clive P; Tran W; Waring M; Goldberg R; Hayward R; Saczynski JS; McManus DD
J Am Heart Assoc; 2020 Mar; 9(6):e014108. PubMed ID: 32146898
[TBL] [Abstract][Full Text] [Related]
11. Inappropriate Underdosing of Direct Oral Anticoagulants in Atrial Fibrillation Patients: Results from the START2-AF Registry.
Poli D; Antonucci E; Ageno W; Berteotti M; Falanga A; Pengo V; Chiarugi P; Cosmi B; Paparo C; Chistolini A; Insana A; Lione D; Malcangi G; Martini G; Masciocco L; Pedrini S; Bucherini E; Pastori D; Pignatelli P; Toma A; Testa S; Palareti G; Start Af Study Group
J Clin Med; 2024 Mar; 13(7):. PubMed ID: 38610775
[No Abstract] [Full Text] [Related]
12. Mortality in Patients With Atrial Fibrillation Receiving Nonrecommended Doses of Direct Oral Anticoagulants.
Camm AJ; Cools F; Virdone S; Bassand JP; Fitzmaurice DA; Arthur Fox KA; Goldhaber SZ; Goto S; Haas S; Mantovani LG; Kayani G; Grierson Turpie AG; Antoon Verheugt FW; Kakkar AK;
J Am Coll Cardiol; 2020 Sep; 76(12):1425-1436. PubMed ID: 32943160
[TBL] [Abstract][Full Text] [Related]
13. Off-label dose direct oral anticoagulants and clinical outcomes in Asian patients with atrial fibrillation: A new evidence of Asian dose.
Xu W; Lv M; Wu T; Huang N; Zhang W; Su J; Dai H; Gu P; Huang X; Du X; Li R; Zheng Q; Lin X; Liu Y; Zhang M; Liu X; Zhu Z; Zhang J
Int J Cardiol; 2023 Jan; 371():184-190. PubMed ID: 36208678
[TBL] [Abstract][Full Text] [Related]
14. Inappropriate direct oral anticoagulant prescriptions in patients with non-valvular atrial fibrillation: cross-sectional analysis of the French CACAO cohort study in primary care.
Ferrat E; Fabre J; Galletout P; Boutin E; Le Breton J; Renard V; Frappé P; Bastuji-Garin S
Br J Gen Pract; 2021; 71(703):e134-e139. PubMed ID: 33495204
[TBL] [Abstract][Full Text] [Related]
15. Thromboembolic and bleeding events with rivaroxaban in clinical practice in Spain: impact of inappropriate doses (the EMIR study).
Fernández MS; Marín F; Rafols C; Arribas F; Barrios V; Cosín-Sales J; Sánchez MA;
J Comp Eff Res; 2021 May; 10(7):583-593. PubMed ID: 33787316
[No Abstract] [Full Text] [Related]
16. Direct Anticoagulants Versus Vitamin K Antagonists in Patients Aged 80 Years or Older With Atrial Fibrillation in a "Real-world" Nationwide Registry: Insights From the FANTASIIA Study.
Ortiz MR; Muñiz J; Esteve-Pastor MA; Marín F; Roldán I; Cequier A; Martínez-Sellés M; Saldivar HG; Bertomeu V; Anguita M
J Cardiovasc Pharmacol Ther; 2020 Jul; 25(4):316-323. PubMed ID: 32228180
[TBL] [Abstract][Full Text] [Related]
17. Inappropriate Dosing of Direct Oral Anticoagulants in Patients with Atrial Fibrillation.
Sugrue A; Sanborn D; Amin M; Farwati M; Sridhar H; Ahmed A; Mehta R; Siontis KC; Mulpuru SK; Deshmukh AJ; Gersh BJ; Asirvatham SJ; Madhavan M
Am J Cardiol; 2021 Apr; 144():52-59. PubMed ID: 33385355
[TBL] [Abstract][Full Text] [Related]
18. Inappropriate prescriptions of direct oral anticoagulants (DOACs) in hospitalized patients: A narrative review.
van der Horst SFB; van Rein N; van Mens TE; Huisman MV; Klok FA
Thromb Res; 2023 Nov; 231():135-140. PubMed ID: 37005194
[TBL] [Abstract][Full Text] [Related]
19. Periprocedural Outcomes of Direct Oral Anticoagulants Versus Warfarin in Nonvalvular Atrial Fibrillation.
Nazha B; Pandya B; Cohen J; Zhang M; Lopes RD; Garcia DA; Sherwood MW; Spyropoulos AC
Circulation; 2018 Oct; 138(14):1402-1411. PubMed ID: 29794081
[TBL] [Abstract][Full Text] [Related]
20. Prior direct oral anticoagulant dosage and outcomes in patients with acute ischemic stroke and non-valvular atrial fibrillation: A sub-analysis of PASTA registry study.
Mashiko T; Fujimoto S; Suda S; Abe A; Iguchi Y; Yagita Y; Kanzawa T; Okubo S; Todo K; Yamazaki M; Nakajima N; Kondo K; Inoue T; Iwanaga T; Terasawa Y; Shibazaki K; Kimura K;
J Neurol Sci; 2022 Mar; 434():120163. PubMed ID: 35121210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
